Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 28 04 2021
received: 24 01 2021
accepted: 12 05 2021
pubmed: 19 5 2021
medline: 29 12 2021
entrez: 18 5 2021
Statut: ppublish

Résumé

Primary cutaneous γδ T-cell lymphomas (PCGDTLs) are a heterogeneous group of lymphomas representing about 1% of primary cutaneous T-cell lymphomas (CTCLs) and mostly regarded as clinically aggressive. Current WHO-EORTC classification recognizes different clinic-pathologic subsets of PCGDTL, but it suggests that cases showing a mycosis fungoides (MF)-like clinical presentation and histopathology should be classified as MF irrespective of phenotype for their indolent course. Herein, we describe a case of γδ-MF, featuring at onset a granulomatous pattern, with subsequent clinical worsening signaled by the development of an ulcero-necrotic lesion and systemic dissemination, leading to death in 5 months. Clinical progression was sustained by a shift to mature T-cell lymphoma composed of medium to large-sized blastoid T-cells featuring a T-cell receptor (TCR) silent immunophenotype.

Identifiants

pubmed: 34002416
doi: 10.1111/cup.14063
doi:

Substances chimiques

Receptors, Antigen, T-Cell 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1197-1203

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
Foppoli M, Ferreri AJ. Gamma-delta T-cell lymphomas. Eur J Haematol. 2015;94(3):206-218.
Chien YH, Meyer C, Bonneville M. γδ T cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121-155. https://doi.org/10.1146/annurev-immunol-032713-120216.
Przybylski GK, Wu H, Macon WR, Finan J, et al. Hepatosplenic and subcutaneous panniculitis-like γ/δ T-cell lymphomas are derived from different Vδ subsets of γ/δ T lymphocytes. J Mol Diagn. 2000;2(1):11-19.
Daniels J, Doukas PG, Escala MEM, et al. Cellular origins and genetic landscape of cutaneous gamma delta T-cell lymphomas. Nat Commun. 2020;11(1):1806.
Jungbluth AA, Frosina D, Fayad M, et al. Immunohistochemical detection of γ/δ T lymphocytes in formalin-fixed paraffin-embedded tissues. Appl Immunohistochem Mol Morphol. 2019;27(8):581-583.
Lee DE, Martinez-Escala EM, Serrano LM, et al. Hemophagocytic lymphohistiocytosis in cutaneous T-cell lymphoma. JAMA Dermatol. 2018;154(7):828-831.
van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
Scarabello A, Leinweber B, Ardigó M, et al. Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas. Am J Surg Pathol. 2002;26(10):1259-1268.
Cerroni L. Cutaneous granulomas and malignant lymphomas. Dermatology. 2003;206(2):78-80.
Kempf W, Ostheeren-Michaelis S, Paulli M, et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC). Arch Dermatol. 2008;144(12):1609-1617.
Guitart J, Weisenburger DD, Subtil A, et al. Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol. 2012;36(11):1656-1665.
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.
Marks E, Shi Y, Wang Y. Two cases of phenotypic switch of primary cutaneous T-cell lymphoma after treatment with an aggressive course and review of the literature. Virchows Arch. 2019;475(5):637-648.
Merrill ED, Agbay R, Miranda RN, et al. Primary cutaneous T-cell lymphomas showing gamma-delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous γδ T-cell lymphomas. Am J Surg Pathol. 2017;41(2):204-215.
Agbay RL, Torres-Cabala CA, Patel KP, et al. Immunophenotypic shifts in primary cutaneous γδ T-cell lymphoma suggest antigenic modulation: a study of sequential biopsy specimens. Am J Surg Pathol. 2017;41(4):431-445.
Garcia-Herrera A, Song JY, Chuang SS, et al. Non hepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35(8):1214-1225.
Chan JK, Chan AC, Cheuk W, et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression. Am J Surg Pathol. 2011;35(10):1557-1569.
Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood. 2004;104(10):3358-3360.
Geissinger E, Sadler P, Roth S, et al. Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations. Haematologica. 2010;95(10):1697-1704.
Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75(11):2213-2219.
Tjon JM, Verbeek WH, Kooy-Winkelaar YM, et al. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood. 2008;112(13):5103-5110.

Auteurs

Dario Tomasini (D)

Medical Department, Division of Dermatology, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Giorgio Alberto Croci (GA)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Division of Pathology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Annamaria Hotz (A)

Department of Diagnostic Services, Division of Pathology, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Stefania Cione (S)

Department of Diagnostic Services, Laboratory Analysis, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Caterina Cecchetti (C)

Oncologic Department, Division of Hematology, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Fabrizio Ciambelli (F)

Oncologic Department, Division of Hematology, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Filippo Crivelli (F)

Department of Diagnostic Services, Division of Pathology, ASST Valle Olona, Hospital of Busto Arsizio, Busto Arsizio (Va), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH